Stevanato Group SpA (NYSE: STVN) — Company Overview, News & Financial Data
Stevanato Group produces pharmaceutical packaging and drug delivery systems, focusing on innovation and safety in healthcare solutions.
Stevanato Group SpA
Stevanato Group SpA is a provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. The company designs, manufactures, and services primary glass packaging, including vials, cartridges, ampoules, and pre-fillable syringes, alongside proprietary and contract-manufactured drug delivery devices such as pen injectors and autoinjectors. Additionally, it produces automated glass converting lines, device assembly machinery, secondary packaging equipment, and visual inspection systems, while providing analytical laboratory testing services for container closure systems across the full drug development lifecycle.
Snapshot
Operations
Products and/or services of Stevanato Group SpA
- Drug Containment Solutions: Design and manufacture of glass primary packaging including pre-fillable syringes, cartridges, vials, and ampoules. The division supplies ready-to-use and standard containers to pharmaceutical companies for biologics, vaccines, and small molecule parenteral drug formulations globally.
- Drug Delivery Systems: Development and contract manufacturing of injectable administration devices, including pen injectors, autoinjectors, wear-on body delivery systems, and customized mechanical components. Operations cover full device lifecycle services from early design and prototyping to large-scale commercial manufacturing.
- Glass Converting Equipment: Engineering and assembly of automated glass converting production lines designed for transforming glass tubing into high-precision pharmaceutical containers, including forming machinery for syringes, cartridges, ampoules, and vials, alongside tooling for precision mechanical engineering.
- Device Assembly and Secondary Packaging Systems: Production of modular assembly platforms and automated secondary packaging equipment, including high-speed assembly machinery, robotic material handling, labeling units, and serialization systems used in pharmaceutical and medical device manufacturing facilities.
- Visual Inspection Systems: Provision of automated, semi-automated, and manual inspection machines incorporating artificial intelligence and computer vision technologies to inspect filled and empty pharmaceutical containers for particulate matter, glass cosmetic defects, and container closure integrity.
- Analytical and Testing Services: Delivery of specialized laboratory testing services for pharmaceutical container closure systems, including chemical analysis, surface characterization, container-drug interaction studies, extractables and leachables testing, and mechanical performance verification of drug delivery devices.
Stevanato Group SpA executive team
- Mr. Franco StevanatoCEO & Executive Chairman
- Mr. Marco Dal LagoChief Financial Officer
- Ms. Lisa MilesChief Communications & Investor Relations Officer
- Ms. Carla CostaChief Human Resources Officer
- Mr. Mauro StocchiChief Business Strategy Officer
- Mr. Michele MonicoPresident of DDS & IVD Business Unit
- Mr. Raffaele PacePresident of Engineering Business Unit